Old Web
English
Sign In
Acemap
>
authorDetail
>
Ralf Hofheinz
Ralf Hofheinz
University of Mannheim
Medicine
Oncology
Internal medicine
Fluorouracil
FOLFIRI
4
Papers
96
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Nivolumab and ipilimumab for second-line therapy in elderly patients with advanced esophageal squamous cell cancer: Safety interim analysis of the RAMONA trial.
2021
Journal of Clinical Oncology
Nicolai Härtel
Nm Meindl-Beinker
Martin Maenz
Wolfgang Hiegl
Johannes Betge
Ralf Hofheinz
Arndt Vogel
S. Angermeier
Claus Bolling
Maike de Wit
Ralf Jakobs
Meinolf Karthaus
Gertraud Stocker
Peter C. Thuss-Patience
Matthias P. Ebert
Show All
Source
Cite
Save
Citations (0)
First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
2012
Journal of Cancer Research and Clinical Oncology
Claus-Henning Köhne
Ralf Hofheinz
Laurent Mineur
H. Letocha
Richard Greil
Josef Thaler
Eva Fernebro
Erick Gamelin
Lucy DeCosta
Meinolf Karthaus
Show All
Source
Cite
Save
Citations (63)
Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study
2012
BMC Cancer
Josef Thaler
Meinolf Karthaus
Laurent Mineur
Richard Greil
H. Letocha
Ralf Hofheinz
Eva Fernebro
Erick Gamelin
Ana Baños
Claus-Henning Köhne
Show All
Source
Cite
Save
Citations (29)
Therapie des Rektumkarzinoms
2010
Onkologie
Claus Rödel
Hans-Peter Bruch
Ralf Hofheinz
Hauke Lang
Dirk Arnold
Show All
Source
Cite
Save
Citations (4)
1